ANI Pharmaceuticals Inc (ANIP) — Cash Flow Quality Index
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Quality Index of 1.10x as of December 2025. Operating cash flow of $30.37 Million exceeds net income of $27.49 Million, indicating high earnings quality where cash backs reported profits. Explore ANI Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ANI Pharmaceuticals Inc Cash Flow Quality Index (2006–2025)
Historical Cash Flow Quality Index for ANI Pharmaceuticals Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ANI Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Quality Index for ANI Pharmaceuticals Inc (2006–2025)
Year-by-year earnings quality comparison for ANI Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.36x | $185.22 Million | $78.34 Million | ▼ -62.7% |
| 2023 | 6.33x | $118.96 Million | $18.78 Million | ▼ -15.4% |
| 2019 | 7.49x | $45.63 Million | $6.09 Million | ▲ +73.0% |
| 2018 | 4.33x | $67.07 Million | $15.49 Million | ▼ -38.0% |
| 2016 | 6.98x | $27.47 Million | $3.93 Million | ▲ +521.9% |
| 2015 | 1.12x | $17.26 Million | $15.38 Million | ▲ +46.5% |
| 2014 | 0.77x | $22.03 Million | $28.75 Million | ▲ +104.2% |
| 2013 | -18.22x | $-5.48 Million | $301.00K | ▼ -917.8% |
| 2006 | -1.79x | $-5.00 Million | $2.79 Million | — |